SYMBIOCELLTECH

symbiocelltech-logo

SymbioCellTech is a biotechnology company that has developed a patented, proprietary therapy to cure insulin-dependent Type I diabetes Mellitus (T1DM), which is commonly referred to as Type 1 or juvenile onset diabetes. In summary it is been shown that through an intra-abdominal administration of SymbioCellTech Neo-Isletsโ„ข (NIs; a cellular therapeutic) has been shown in multiple animal models of Type 1 Diabetes to result in long-term glucose control with reduced or no need for insulin injecti... ons, and with no need for toxic antirejection drugs. The durable blood glucose control along with the absence of an immune response demonstrate that NIs provide protection from autoimmune attacks that ordinarily destroy insulin-producing cells in Type 1 Diabetes, and provide an endogenous and physiologic source of insulin.

#SimilarOrganizations #People #Website #More

SYMBIOCELLTECH

Social Links:

Industry:
Biopharma Biotechnology Diabetes Health Care Medical Pharmaceutical Therapeutics

Founded:
2006-04-25

Address:
Salt Lake City, Utah, United States

Country:
United States

Website Url:
http://www.symbiocelltech.com

Total Employee:
1+

Status:
Active

Contact:
8016435970

Email Addresses:
[email protected]

Total Funding:
15.53 M USD

Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Google Tag Manager Google Analytics Google Maps Content Delivery Network Global Site Tag Organization Schema Google Universal Analytics


Similar Organizations

cabaletta-bio-logo

Cabaletta Bio

Cabaletta Bio has adapted clinically-validated and FDA-approved CAR T cell technology to target B cell-mediated autoimmune diseases.

carisma-therapeutics-logo

Carisma Therapeutics

Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.

lucaspye-bio-logo

LucasPye BIO

A Contract Development and Manufacturing Organization (CDMO) that manufactures protein-therapeutic and viral-therapeutic drug products.

rainier-therapeutics-logo

Rainier Therapeutics

Rainier Therapeutics is a developer of cancer therapeutics technology intended to offer advanced targeted therapy for bladder cancer.

semma-therapeutics-logo

Semma Therapeutics

Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.

tcr2-logo

TCR2

TCR2 is a discovery stage pharmaceutical company that developed a unique proprietary TRuCโ„ข platform.

verismo-therapeutics-logo

Verismo Therapeutics

Verismo Therapeutics develops novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer.

Current Employees Featured

christof-westenfelder_image

Christof Westenfelder
Christof Westenfelder Founder and CEO @ SymbioCellTech
Founder and CEO

not_available_image

Anna Gooch
Anna Gooch Chief Scientific Officer @ SymbioCellTech
Chief Scientific Officer

travis-manning_image

Travis Manning
Travis Manning Chief Operating Officer @ SymbioCellTech
Chief Operating Officer
2022-07-01

not_available_image

LeAnne Swenson
LeAnne Swenson CMO @ SymbioCellTech
CMO

Founder


christof-westenfelder_image

Christof Westenfelder

Official Site Inspections

http://www.symbiocelltech.com Semrush global rank: 4.77 M Semrush visits lastest month: 1.89 K

  • Host name: 198.185.159.145
  • IP address: 198.185.159.145
  • Location: New York United States
  • Latitude: 40.7157
  • Longitude: -74
  • Metro Code: 501
  • Timezone: America/New_York
  • Postal: 10013

Loading ...

More informations about "SymbioCellTech"

SymbioCellTech

Click here to learn more about the science behind SymbioCellTech's โ€œNeo-Isletโ€ technology Learn More About Our Technology โ†’ SymbioCellTech LLC, 615 Arapeen Drive, Salt Lake City, UT, โ€ฆSee details»

SymbioCellTech - Crunchbase Company Profile

SymbioCellTech is a biotechnology company that has developed a patented, proprietary therapy to cure insulin-dependent Type I diabetes Mellitus (T1DM), โ€ฆSee details»

SYMBIOCELLTECH, LLC Company Profile - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for SYMBIOCELLTECH, LLC of Salt Lake City, UT. Get the latest business insights from Dun & โ€ฆSee details»

SymbioCellTech, LLC - LinkedIn

SymbioCellTech, LLC | 236 followers on LinkedIn. Aiming for a functional cure to Type 1 Diabetes | SymbioCellTech (SCT) is an early stage, university spin out, that has developed stem cell โ€ฆSee details»

SymbioCellTech LLC - Drug pipelines, Patents, Clinical trials

Explore SymbioCellTech LLC with its drug pipeline, therapeutic area, technology platform, 2 news, and 2 literature, Disease Domain:Endocrinology and Metabolic Disease, Immune โ€ฆSee details»

Team โ€” SymbioCellTech

Gosink is an entrepreneurial mentor for the University of California Riverside and serves as a Strategic Advisor for SymbioCellTech. Meet Our Board โ†’ SymbioCellTech LLC, 615 Arapeen โ€ฆSee details»

SymbioCellTech 2025 Company Profile: Valuation, Funding

SymbioCellTech General Information Description. Developer of cell-based therapies designed to provide a permanent functional cure for diabetes. The company's adult stem cell-based โ€ฆSee details»

SymbioCellTech - Overview, News & Similar companies - ZoomInfo

Aug 23, 2023 Who is SymbioCellTech. SymbioCellTech, LLC, is a privately held biotechnology company located in Salt Lake City, Utah, developing proprietary technology for a fundamental โ€ฆSee details»

SymbioCellTech | Biotechnology - BioUtah

SymbioCellTech, LLC, SCT, a Regenerative Medicine Company, was established by clinical academic investigators at the University of Utah, Salt Lake City, USA and University of โ€ฆSee details»

SymbioCellTech, LLC - VentureRadar

SymbioCellTech, LLC VentureRadar profile. Find out more about SymbioCellTech, LLC including the VentureRadar Innovation and Growth scores, Similar Companies and more.See details»

SymbioCellTech, LLC - Leadership Team - The Org

The Leadership Team at SymbioCellTech, LLC is responsible for steering the company's strategic direction and overseeing the development of its innovative therapy for Type 1 diabetes. This โ€ฆSee details»

SymbioCellTech - Contacts, Employees, Board Members, Advisors โ€ฆ

SymbioCellTech has 4 current employee profiles, including Founder and CEO Christof Westenfelder. Christof Westenfelder Founder and CEO Anna Gooch Chief Scientific OfficerSee details»

Technology โ€” SymbioCellTech

SymbioCellTech Technology. SymbioCellTech (SCT) has developed and patented the technology for a fundamentally new adult stem cell-enabled therapy in which culture-expanded insulin โ€ฆSee details»

SymbioCellTech - Funding, Financials, Valuation & Investors

Organization. SymbioCellTech . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Funding Rounds 3. obfuscated. โ€ฆSee details»

SymbioCellTech - Altitude Lab

SymbioCellTech, LLC (SCT), a late preclinical stage regenerative medicine company based in Salt Lake City, Utah, was established by clinical academic investigators at the University of โ€ฆSee details»

SymbioCellTech Demonstrates Preclinical Efficacy of ... - Newswire

Oct 28, 2021 SymbioCellTech, LLC is a privately held biotechnology company in Salt Lake City, UT, focused on the development of stem cell therapies for the treatment of diabetes, โ€ฆSee details»

SymbioCellTech - Updates, News, Events, Signals & Triggers

Research and development company in biotechnology aiming for a functional cure to diabetes through patented Neo-Isletsโ„ข technologySee details»

NeoIslets: Innovation Challenge Winner at ADA Scientific Session

Aug 13, 2024 SymbioCellTech LLC, 615 Arapeen Drive, Salt Lake City, UT, 84108, United States 801.503.3990 or 801.643.5970 [email protected]See details»

Scientists program stem cells to mimic first days of embryonic โ€ฆ

Mar 20, 2025 The earliest days after fertilization, once a sperm cell meets an egg, are shrouded in scientific mystery. The process of how a humble single cell becomes an organism โ€ฆSee details»

SymbioCellTech Wins ADA Innovation Challenge for โ€ฆ

Jun 24, 2024 SymbioCellTech's CSO Anna Gooch, PhD, to Present on Neo-Isletโ„ข Technology at ADA 84th Scientific Sessions. SymbioCellTech LLC, 615 Arapeen Drive, Salt Lake City, UT, โ€ฆSee details»

linkstock.net © 2022. All rights reserved